Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and other pharmaceutical companies. They also provide contract manufacturing services.
Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and otherpharmaceutical companies. They also provide contract manufacturingservices.
I like the high earnings estimate revisions.
Zacks Rank and Recommendation are both rated #1
current qt earnings estimate revision change 21%
next qt earnings estimate revision change 28.5%
earnings surprise last qt up 100%
PEG 1.2
ROE 20%
operating margin 18.5 %
debt/equity 0.73
current ratio 9.96
I coulda sweard I had thisn on me list. Not too late as thur is palenty o'downside coming. 9.4 nein! nein! nein! wuz a LTCT ann todaze 9.155 high is already showing as a CT...mit a 'telemagraphed" low ov 8.51 basides. I'll post the trendies ifn whenst I find em. 3J
I coulda sweard I had thisn on me list. Not too late as thur is palenty o'downside coming. 9.4 nein! nein! nein! wuz a LTCT ann todaze 9.155 high is already showing as a CT...mit a 'telemagraphed" low ov 8.51 basides. I'll post the trendies ifn whenst I find em. 3J
I like the high earnings estimate revisions.
Zacks Rank and Recommendation are both rated #1
current qt earnings estimate revision change 21%
next qt earnings estimate revision change 28.5%
earnings surprise last qt up 100%
PEG 1.2
ROE 20%
operating margin 18.5 %
debt/equity 0.73
current ratio 9.96
Take advantage of quick short-term moves, and profit from price moves in any direction. Trade options under the direction of an expert guide. Try it now and get a 90-day unconditional money-back guarantee. 50% OFF for a limited time! Zacks Options Trader >>
Find Winning Stocks Quickly with Research Wizard, a powerful desktop software program. Start with easy-to-use pre-loaded strategies, then develop your own. Backtest against years of historical data to see how your approach works in any market. Start a Free Trial Today >>
With Zacks Method for Trading you'll transform yourself into a Master Stock Trader, one simple step at a time. Get step-by-step instructions and learn how to use the 28% per year Zacks Rank system to find market-beating stocks on your own, fully exploiting the system that beat the market 18 of the last 20 years. Find out how >>
Comments: 0 | Comment
Comments: 10 | Comment
Comments: 0 | Comment
Zacks Rank and Recommendation are both rated #1
current qt earnings estimate revision change 21%
next qt earnings estimate revision change 28.5%
earnings surprise last qt up 100%
PEG 1.2
ROE 20%
operating margin 18.5 %
debt/equity 0.73
current ratio 9.96
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment